These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19606707

  • 41. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M.
    Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
    [Abstract] [Full Text] [Related]

  • 42. Transient menorrhagia without adalimumab discontinuation in a patient with Crohn's disease.
    Katsanos KH, Tsianos VE, Tsianos EV.
    J Crohns Colitis; 2010 Sep; 4(3):348. PubMed ID: 21122527
    [No Abstract] [Full Text] [Related]

  • 43. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease.
    Sandborn WJ.
    Rev Gastroenterol Disord; 2004 Sep; 4 Suppl 3():S25-33. PubMed ID: 15583528
    [Abstract] [Full Text] [Related]

  • 44. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease.
    Vannucchi V, Grazzini M, Pieralli F, Giannotta M, Biagioni C, Nozzoli C.
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):201-3. PubMed ID: 21725519
    [Abstract] [Full Text] [Related]

  • 45. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
    Nobile S, Gionchetti P, Rizzello F, Calabrese C, Campieri M.
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
    [Abstract] [Full Text] [Related]

  • 46. Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.
    Zorzi F, Zuzzi S, Onali S, Calabrese E, Condino G, Petruzziello C, Ascolani M, Pallone F, Biancone L.
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1397-407. PubMed ID: 22519466
    [Abstract] [Full Text] [Related]

  • 47. Duodenal Crohn's disease successfully treated with adalimumab.
    Tursi A.
    Endoscopy; 2011 Jun; 43 Suppl 2 UCTN():E22. PubMed ID: 21271523
    [No Abstract] [Full Text] [Related]

  • 48. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F, Fiorino G, Danese S.
    Expert Rev Clin Immunol; 2015 Jun; 11(9):963-72. PubMed ID: 26211396
    [Abstract] [Full Text] [Related]

  • 49. Adalimumab, a novel anti-tumor necrosis factor-alpha antibody in a child with refractory Crohn's disease.
    Mian S, Baron H.
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):357-9. PubMed ID: 16131995
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
    Salar A, Bessa X, Muñiz E, Monfort D, Besses C, Andreu M.
    Gut; 2007 Aug; 56(8):1169-70. PubMed ID: 17344276
    [No Abstract] [Full Text] [Related]

  • 54. Acute lymphoid leukemia in a Crohn's disease patient during treatment with adalimumab after a prolonged treatment with azathioprine and steroids.
    Cesarini M, Vernia P, Angelucci E.
    Inflamm Bowel Dis; 2010 Mar; 16(3):371-2. PubMed ID: 19637388
    [No Abstract] [Full Text] [Related]

  • 55. [Efficacy and safety of Adalimumab in Crohn's disease].
    Serghini M, Haddad W, Jeddi H, Karoui S, Ben Mustapha N, Kallel L, Fekih M, Matri S, Boubaker J, Filali A.
    Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
    Kump PK, Högenauer C, Wenzl HH, Petritsch W.
    J Crohns Colitis; 2013 Feb; 7(1):e15-8. PubMed ID: 22770648
    [Abstract] [Full Text] [Related]

  • 58. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
    Casanova MJ, Chaparro M, Valenzuela C, Cisneros C, Gisbert JP.
    World J Gastroenterol; 2015 Feb 21; 21(7):2260-2. PubMed ID: 25717268
    [Abstract] [Full Text] [Related]

  • 59. Natalizumab (Tysabri) for Crohn's disease.
    Med Lett Drugs Ther; 2008 May 05; 50(1285):34-6. PubMed ID: 18458669
    [No Abstract] [Full Text] [Related]

  • 60. Sarcoidosis during infliximab therapy for Crohn's disease.
    Takahashi H, Kaneta K, Honma M, Ishida-Yamamoto A, Ashida T, Kohgo Y, Ohsaki Y, Iizuka H.
    J Dermatol; 2010 May 05; 37(5):471-4. PubMed ID: 20536653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.